Advertisement
Document › Details
Andera Partners. (4/27/21). "Press Release: Andera Partners Strengthens Its Presence in the DACH Region".
Region | München (Munich) | |
Country | Germany | |
Organisation | Andera Partners (FR) | |
Organisation 2 | T-Knife GmbH | |
Group | T-Knife (Group) | |
Product | venture capital | |
Product 2 | LIFE SCIENCES | |
Person | Litzka, Olivier (Andera Partners 202104 Partner Life Sciences + Coordinator DACH before EdRIP + 3i Venture Healthcare) | |
Person 2 | Wisniewski, Raphaël (Andera Partners 202110 formerly LCF Rothschild at Edmond de Rothschild Investment Partners) | |
Andera Partners is strengthening its presence in the DACH region (Germany, Austria, German speaking Switzerland) by opening an office in Munich.
The management company has already been active in this region for several years, notably through its Andera Life Sciences activity. It has invested in companies such as Jenavalve, Noxxon, Probiodrug, and Allecra and, more recently, in T-Knife, Exciva and Tricares. Andera Partners will continue to focus on the biotech and medtech sectors in these markets, while preparing the ground for its SME, Mezzanine and Renewable Energy and Infrastructure funds.
“The German, Austrian and German speaking Swiss markets have traditionally been an interesting place for us to invest in exciting Life Sciences companies, and the region has become even more attractive recently. It therefore seemed appropriate and timely to strengthen our presence in these geographies with a local presence” said Olivier Litzka, Partner at Andera Life Sciences and coordinator of DACH activities. “Our interest in the DACH region is clearly threefold: 1/ Being closer to the ecosystem to identify the rising stars of life sciences companies, 2/ exploring opportunities for our growth capital, buy out, sponsorless mezzanine, renewable energy and infrastructure funds and 3/ attracting institutional investors as well as major family offices in Germany, Austria and Switzerland into our Andera family of funds.”
“We are highly committed to the DACH region, as demonstrated by the fact, that Olivier has now relocated from Paris to Munich to coordinate Andera Partners’ efforts to expand into the region. We have a true ambition to further grow pan-European and a partner building a presence is the ideal way to do it” said Raphael Wisniewski and Sylvain Charignon, the two Managing Partners of Andera Partners.
With more than 20 years of VC experience, 15 of which as a partner with Andera Life Sciences, Olivier Litzka, PhD, has extensive expertise with biotech and medtech startup companies, as well as with building relationships with Limited Partners.
Beyond its initial Life Sciences focus, the Munich office represents an additional showcase for Andera Partners’ overall activities in the DACH markets as well as a further step in Andera Partners’ international strategy. With existing offices in France and in Belgium, the DACH countries represent a third European region of priority for Andera Partners, on top of its investment activities in other European countries and in the US.
Record changed: 2023-06-05 |
Advertisement
More documents for Andera Partners (FR)
- [1] Andera Partners. (11/13/24). "Press Release: Andera Partners Continues Its International Expansion and Announces the Opening of a Madrid Office". Paris & Madrid....
- [2] SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich....
- [3] Nouscom AG. (11/14/23). "Press Release: Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round". Basel....
- [4] Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin....
- [5] Andera Partners. (2/16/23). "Press Release: Ahead of Its Business Plan, Andera Partners Approaches 4 Billion Euros in Assets Under Management and Announces a New 2028 Target of 6 to 8 Billion Euros". Paris....
- [6] Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris....
- [7] Andera Partners. (7/7/22). "Press Release: Andera Partners Strengthens Its Life Sciences Team with a New Partner"....
- [8] Mineralys Therapeutics, Inc.. (6/8/22). "Press Release: Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension". Philadeliphia, PA....
- [9] Tubulis GmbH. (5/3/22). "Press Release: Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies". Munich....
- [10] Exciva GmbH. (10/26/21). "Press Release: Exciva Raises €9 Million in Series A Round Led by Andera Partners". Heidelberg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top